{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:42:54Z","timestamp":1787654574236,"version":"build-2736575974"},"reference-count":44,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,16]]},"DOI":"10.20945\/2359-3997000000392","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T20:01:55Z","timestamp":1627675315000},"source":"Crossref","is-referenced-by-count":10,"title":["Adrenal crisis and mortality rate in adrenal insufficiency and congenital adrenal hyperplasia"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1170-253X","authenticated-orcid":false,"given":"Lia Mesquita","family":"Lousada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-1084","authenticated-orcid":false,"given":"Berenice B.","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5219-3153","authenticated-orcid":false,"given":"Tania A. S. S.","family":"Bachega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"6","key":"key20210730160141_B1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ando.2017.10.010","article-title":"Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality","volume":"78","author":"Chabre","year":"2017","unstructured":"1. Chabre O, Goichot B, Zenaty D, Bertherat J. Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality. Ann Endocrinol (Paris). 2017;78(6):490-4.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"key20210730160141_B2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline","volume":"101","author":"Bornstein","year":"2016","unstructured":"2. Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364-89.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5362","key":"key20210730160141_B3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/bmj.2.5362.887","article-title":"Eighty-six cases of Addison's disease","volume":"2","author":"Dunlop","year":"1963","unstructured":"3. Dunlop D. Eighty-six cases of Addison's disease. Br Med J. 1963;2(5362):887-91.","journal-title":"Br Med J"},{"issue":"7571","key":"key20210730160141_B4","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(68)90948-3","article-title":"Epidemiological and clinical picture of Addison's disease","volume":"2","author":"Mason","year":"1968","unstructured":"4. Mason AS, Meade TW, Lee JA, Morris JN. Epidemiological and clinical picture of Addison's disease. Lancet. 1968;2(7571):744-7.","journal-title":"Lancet"},{"issue":"4","key":"key20210730160141_B5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpeds.2003.12.036","article-title":"Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients","volume":"144","author":"Mills","year":"2004","unstructured":"5. Mills JL, Schonberger LB, Wysowski DK, Brown P, Durako SJ, Cox C, et al. Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr. 2004;144(4):430-6.","journal-title":"J Pediatr"},{"issue":"12","key":"key20210730160141_B6","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","unstructured":"6. Bergthorsdottir R, Leonsson-Zachrisson M, Oden A, Johannsson G. Premature mortality in patients with Addison's disease: a population-based study. J Clin Endocrinol Metab. 2006;91(12):4849-53.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key20210730160141_B7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","unstructured":"7. Erichsen MM, Lovas K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J, et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol. 2009;160(2):233-7.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key20210730160141_B8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0032-1324724","article-title":"Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood","volume":"30","author":"White","year":"2012","unstructured":"8. White PC, Bachega TA. Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood. Semin Reprod Med. 2012;30(5):400-9.","journal-title":"Semin Reprod Med"},{"issue":"12","key":"key20210730160141_B9","first-page":"4416","article-title":"Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency","volume":"83","author":"Bachega","year":"1998","unstructured":"9. Bachega TA, Billerbeck AE, Madureira G, Marcondes JA, Longui CA, Leite MV, et al. Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 1998;83(12):4416-9.","journal-title":"J Clin Endocrinol Metab"},{"key":"key20210730160141_B10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cca.2018.07.039","article-title":"Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China","volume":"486","author":"Su","year":"2018","unstructured":"10. Su L, Yin X, Cheng J, Cai Y, Wu D, Feng Z, et al. Clinical presentation and mutational spectrum in a series of 166 patients with classical 21-hydroxylase deficiency from South China. Clin Chim Acta. 2018;486:142-50.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"key20210730160141_B11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7196\/SAMJ.2018.v108i2.12579","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency in South Africa","volume":"108","author":"Ganie","year":"2018","unstructured":"11. Ganie Y, Aldous C, Balakrishna Y, Wiersma R. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency in South Africa. S Afr Med J. 2018;108(2):132-7.","journal-title":"S Afr Med J"},{"issue":"4","key":"key20210730160141_B12","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/cen.13292","article-title":"Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening","volume":"86","author":"Hayashi","year":"2017","unstructured":"12. Hayashi GY, Carvalho DF, de Miranda MC, Faure C, Vallejos C, Brito VN, et al. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening. Clin Endocrinol (Oxf). 2017;86(4):480-7.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key20210730160141_B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.endinu.2017.11.001","article-title":"Newborn screening of congenital adrenal hyperplasia","volume":"65","author":"Dul\u00edn I\u00f1iguez","year":"2018","unstructured":"13. Dul\u00edn I\u00f1iguez E, Ezquieta Zubicaray B. Newborn screening of congenital adrenal hyperplasia. Endocrinol Diabetes Nutr. 2018;65(1):1-4.","journal-title":"Endocrinol Diabetes Nutr"},{"issue":"3","key":"key20210730160141_B14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ymgme.2015.08.004","article-title":"Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states","volume":"116","author":"Held","year":"2015","unstructured":"14. Held PK, Shapira SK, Hinton CF, Jones E, Hannon WH, Ojodu J. Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states. Mol Genet Metab. 2015;116(3):133-8.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"key20210730160141_B15","doi-asserted-by":"crossref","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","article-title":"Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","unstructured":"15. Falhammar H, Frisen L, Norrby C, Hirschberg AL, Almqvist C, Nordenskjold A, et al. Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2014;99(12):E2715-21.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key20210730160141_B16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0022-3476(98)70060-5","article-title":"Mortality in patients with congenital adrenal hyperplasia: a cohort study","volume":"133","author":"Swerdlow","year":"1998","unstructured":"16. Swerdlow AJ, Higgins CD, Brook CG, Dunger DB, Hindmarsh PC, Price DA, et al. Mortality in patients with congenital adrenal hyperplasia: a cohort study. J Pediatr. 1998;133(4):516-20.","journal-title":"J Pediatr"},{"issue":"4","key":"key20210730160141_B17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EJE-17-0895","article-title":"Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia","volume":"178","author":"Jenkins-Jones","year":"2018","unstructured":"17. Jenkins-Jones S, Parviainen L, Porter J, Withe M, Whitaker MJ, Holden SE, et al. Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia. Eur J Endocrinol. 2018;178(4):309-20.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"key20210730160141_B18","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1515\/jpem-2017-0068","article-title":"Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency","volume":"30","author":"Mooij","year":"2017","unstructured":"18. Mooij CF, van Herwaarden AE, Sweep F, Roeleveld N, de Korte CL, Kapusta L, et al. Cardiovascular and metabolic risk in pediatric patients with congenital adrenal hyperplasia due to 21 hydroxylase deficiency. J Pediatr Endocrinol Metab. 2017;30(9):957-66.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"6","key":"key20210730160141_B19","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/jcp.2009.064477","article-title":"Fatal Addison's disease in a teenager","volume":"62","author":"Suvarna","year":"2009","unstructured":"19. Suvarna SK. Fatal Addison's disease in a teenager. J Clin Pathol. 2009;62(6):573-4.","journal-title":"J Clin Pathol"},{"issue":"8","key":"key20210730160141_B20","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/adc.57.8.572","article-title":"Sudden natural death in later childhood and adolescence","volume":"57","author":"Molander","year":"1982","unstructured":"20. Molander N. Sudden natural death in later childhood and adolescence. Arch Dis Child. 1982;57(8):572-6.","journal-title":"Arch Dis Child"},{"issue":"10","key":"key20210730160141_B21","first-page":"859","article-title":"Failure to diagnose: Addison disease","volume":"36","author":"Bird","year":"2007","unstructured":"21. Bird S. Failure to diagnose: Addison disease. Aust Fam Physician. 2007;36(10):859-61.","journal-title":"Aust Fam Physician"},{"issue":"3","key":"key20210730160141_B22","doi-asserted-by":"crossref","first-page":"339.e1","DOI":"10.1016\/j.amjmed.2015.08.021","article-title":"Adrenal Crisis: Still a Deadly Event in the 21st Century","volume":"129","author":"Puar","year":"2016","unstructured":"22. Puar TH, Stikkelbroeck NM, Smans LC, Zelissen PM, Hermus AR. Adrenal Crisis: Still a Deadly Event in the 21st Century. Am J Med. 2016;129(3):339.e1-9.","journal-title":"Am J Med"},{"key":"key20210730160141_B23","first-page":"448","article-title":"The Key to Adrenal Insufficiency Education: Repetition, Repetition, Repetition","volume":"14","author":"Keil","year":"2017","unstructured":"23. Keil MF, Van Ryzin C. The Key to Adrenal Insufficiency Education: Repetition, Repetition, Repetition. Pediatr Endocrinol Rev. 2017;14(Suppl 2):448-53.","journal-title":"Pediatr Endocrinol Rev"},{"key":"key20210730160141_B24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1749-6632.1987.tb35749.x","article-title":"Interleukin-1 and glucocorticoid hormones integrate an immunoregulatory feedback circuit","volume":"496","author":"Del Rey","year":"1987","unstructured":"24. Del Rey A, Besedovsky H, Sorkin E, Dinarello CA. Interleukin-1 and glucocorticoid hormones integrate an immunoregulatory feedback circuit. Ann N Y Acad Sci. 1987;496:85-90.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"key20210730160141_B25","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/EJE-09-0884","article-title":"Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies","volume":"162","author":"Hahner","year":"2010","unstructured":"25. Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M, et al. Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol. 2010;162(3):597-602.","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"key20210730160141_B26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMra1807486","article-title":"Adrenal Crisis","volume":"381","author":"Rushworth","year":"2019","unstructured":"26. Rushworth RL, Torpy DJ, Falhammar H. Adrenal Crisis. N Engl J Med. 2019;381(9):852-61.","journal-title":"N Engl J Med"},{"issue":"3","key":"key20210730160141_B27","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-14-0824","article-title":"Extensive expertise in endocrinology. Adrenal crisis","volume":"172","author":"Allolio","year":"2015","unstructured":"27. Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol. 2015;172(3):R115-24.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key20210730160141_B28","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrendo.2010.211","article-title":"Addisonian crisis in a young man with atypical anorexia nervosa","volume":"7","author":"Allolio","year":"2011","unstructured":"28. Allolio B, Lang K, Hahner S. Addisonian crisis in a young man with atypical anorexia nervosa. Nat Rev Endocrinol. 2011;7(2): 115-21.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"key20210730160141_B29","first-page":"55","article-title":"How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions","volume":"21","author":"Sapolsky","year":"2000","unstructured":"29. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev. 2000;21(1): 55-89.","journal-title":"Endocr Rev"},{"issue":"27","key":"key20210730160141_B30","first-page":"1497","article-title":"Addisonian crisis in patients with known adrenal insufficiency: the importance of early intervention","volume":"152","author":"Mulder","year":"2008","unstructured":"30. Mulder AH, Nauta S, Pieters GF, Hermus AR. [Addisonian crisis in patients with known adrenal insufficiency: the importance of early intervention]. Ned Tijdschr Geneeskd. 2008;152(27):1497-500.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"1","key":"key20210730160141_B31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s001340050021","article-title":"Adrenal crisis presenting as hypoglycemic coma","volume":"26","author":"Fischer","year":"2000","unstructured":"31. Fischer JE, Stallmach T, Fanconi S. Adrenal crisis presenting as hypoglycemic coma. Intensive Care Med. 2000;26(1):105-8.","journal-title":"Intensive Care Med"},{"issue":"1","key":"key20210730160141_B32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-09-0559","article-title":"Adrenal crisis in treated Addison's disease: a predictable but under-managed event","volume":"162","author":"White","year":"2010","unstructured":"32. White K, Arlt W. Adrenal crisis in treated Addison's disease: a predictable but under-managed event. Eur J Endocrinol. 2010;162(1):115-20.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key20210730160141_B33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","unstructured":"33. Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D, et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab. 2015;100(2):407-16.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key20210730160141_B34","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/js.2019-00263","article-title":"Prehospital Management of Acute Addison Disease: Audit of Patients Attending a Referral Hospital in a Regional Area","volume":"3","author":"Goubar","year":"2019","unstructured":"34. Goubar T, Torpy DJ. Prehospital Management of Acute Addison Disease: Audit of Patients Attending a Referral Hospital in a Regional Area. J Endocr Soc. 2019;3(12):2194-203.","journal-title":"J Endocr Soc"},{"issue":"1","key":"key20210730160141_B35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jim-2019-000999","article-title":"Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings","volume":"68","author":"Miller","year":"2020","unstructured":"35. Miller BS, Spencer SP, Geffner ME, Gourgari E, Lahoti A, Kamboj MK, et al. Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings. J Investig Med. 2020;68(1):16-25.","journal-title":"J Investig Med"},{"issue":"1","key":"key20210730160141_B36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-12-0161","article-title":"Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency","volume":"167","author":"Reisch","year":"2012","unstructured":"36. Reisch N, Willige M, Kohn D, Schwarz HP, Allolio B, Reincke M, et al. Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur J Endocrinol. 2012;167(1):35-42.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"key20210730160141_B37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency","volume":"3","author":"Bancos","year":"2015","unstructured":"37. Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol. 2015;3(3):216-26.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"key20210730160141_B38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye","year":"2014","unstructured":"38. Husebye ES, Allolio B, Arlt W, Badenhoop K, Bensing S, Betterle C, et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med. 2014;275(2):104-15.","journal-title":"J Intern Med"},{"issue":"3","key":"key20210730160141_B39","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s12020-021-02649-6","article-title":"Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis","volume":"71","author":"Nowotny","year":"2021","unstructured":"39. Nowotny H, Ahmed SF, Bensing S, Beun JG, Br\u00f6samle M, Chifu I, et al. Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. Endocrine. 2021;71(3):586-94.","journal-title":"Endocrine"},{"issue":"2","key":"key20210730160141_B40","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-1612","article-title":"Adrenal insufficiency: still a cause of morbidity and death in childhood","volume":"119","author":"Shulman","year":"2007","unstructured":"40. Shulman DI, Palmert MR, Kemp SF. Adrenal insufficiency: still a cause of morbidity and death in childhood. Pediatrics. 2007;119(2):e484-94.","journal-title":"Pediatrics"},{"issue":"6","key":"key20210730160141_B41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ando.2017.10.008","article-title":"Group 5: Acute adrenal insufficiency in adults and pediatric patients","volume":"78","author":"Cortet","year":"2017","unstructured":"41. Cortet C, Barat P, Zenaty D, Guignat L, Chanson P. Group 5: Acute adrenal insufficiency in adults and pediatric patients. Ann Endocrinol (Paris). 2017;78(6):535-43.","journal-title":"Ann Endocrinol (Paris)"},{"issue":"4","key":"key20210730160141_B42","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00000658-199404000-00013","article-title":"Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem","volume":"219","author":"Salem","year":"1994","unstructured":"42. Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg. 1994;219(4):416-25.","journal-title":"Ann Surg"},{"issue":"3","key":"key20210730160141_B43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2753.2009.01149.x","article-title":"Cortisone replacement therapy in endocrine disorders - quality of self-care","volume":"16","author":"Harsch","year":"2010","unstructured":"43. Harsch IA, Schuller A, Hahn EG, Hensen J. Cortisone replacement therapy in endocrine disorders - quality of self-care. J Eval Clin Pract. 2010;16(3):492-8.","journal-title":"J Eval Clin Pract"},{"issue":"6","key":"key20210730160141_B44","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1530\/EJE-13-0450","article-title":"Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe","volume":"169","author":"Grossman","year":"2013","unstructured":"44. Grossman A, Johannsson G, Quinkler M, Zelissen P. Therapy of endocrine disease: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe. Eur J Endocrinol. 2013;169(6):R165-75.","journal-title":"Eur J Endocrinol"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T18:16:14Z","timestamp":1699294574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/j\/aem\/a\/8CD83Sd9jNmX8Jr3bDdjRky\/?lang=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":44,"alternative-id":["10.20945\/2359-3997000000392"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000392","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}